KMDA logo

Kamada Ltd


KMDA: Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.


Show KMDA Financials

Consumer Interest
SEC Filings

Recent trades of KMDA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by KMDA's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods and uses of alpha 1-antitrypsin for early intervention in pulmonary diseases Mar. 30, 2021
  • Patent Title: Compositions derived from cohn fraction paste and use thereof Jul. 28, 2020
  • Patent Title: Therapy and prophylaxis of infectious disease caused by zika virus Jun. 23, 2020
  • Patent Title: Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases Jul. 05, 2011
  • Patent Title: Large scale preparation of alpha-1 proteinase inhibitor and use thereof Feb. 01, 2011
Government Contracts

Federal grants, loans, and purchases


Number of mentions of KMDA in WallStreetBets Daily Discussion


Recent insights relating to KMDA

CNBC Recommendations

Recent picks made for KMDA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KMDA

Corporate Flights

Flights by private jets registered to KMDA